Dignitana AB (publ.)
Dignitana AB (publ), a medical technology company, engages in the development, production, and marketing of medical cooling devices in the United States and internationally. It offers DigniCap, a scalp cooling system used to reduce hair loss from chemotherapy treatments, as well as for patients receiving chemotherapy to treat other solid tumors. The company was incorporated in 2007 is headquarter… Read more
Market Cap & Net Worth: Dignitana AB (publ.) (DIZTF)
Dignitana AB (publ.) (PINK:DIZTF) has a market capitalization of $13.69 Million ($13.69 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #29279 globally and #9710 in its home market, demonstrating a -15.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dignitana AB (publ.)'s stock price $0.17 by its total outstanding shares 80541904 (80.54 Million).
Dignitana AB (publ.) Market Cap History: 2015 to 2025
Dignitana AB (publ.)'s market capitalization history from 2015 to 2025. Data shows change from $133.06 Million to $13.69 Million (-17.50% CAGR).
Dignitana AB (publ.) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dignitana AB (publ.)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.12x
Dignitana AB (publ.)'s market cap is 0.12 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $133.06 Million | $4.75 Million | -$16.57 Million | 28.02x | N/A |
| 2016 | $110.02 Million | $8.90 Million | -$32.27 Million | 12.36x | N/A |
| 2017 | $34.30 Million | $22.94 Million | -$42.60 Million | 1.50x | N/A |
| 2018 | $43.50 Million | $33.74 Million | -$26.02 Million | 1.29x | N/A |
| 2019 | $76.51 Million | $40.70 Million | -$38.03 Million | 1.88x | N/A |
| 2020 | $81.75 Million | $46.63 Million | -$52.96 Million | 1.75x | N/A |
| 2021 | $72.49 Million | $57.07 Million | -$43.09 Million | 1.27x | N/A |
| 2022 | $24.16 Million | $73.00 Million | -$22.41 Million | 0.33x | N/A |
| 2023 | $13.69 Million | $86.06 Million | -$17.36 Million | 0.16x | N/A |
| 2024 | $10.47 Million | $89.83 Million | -$19.18 Million | 0.12x | N/A |
Competitor Companies of DIZTF by Market Capitalization
Companies near Dignitana AB (publ.) in the global market cap rankings as of March 19, 2026.
Key companies related to Dignitana AB (publ.) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Dignitana AB (publ.) Historical Marketcap From 2015 to 2025
Between 2015 and today, Dignitana AB (publ.)'s market cap moved from $133.06 Million to $ 13.69 Million, with a yearly change of -17.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $13.69 Million | +30.77% |
| 2024 | $10.47 Million | -23.53% |
| 2023 | $13.69 Million | -43.33% |
| 2022 | $24.16 Million | -66.67% |
| 2021 | $72.49 Million | -11.33% |
| 2020 | $81.75 Million | +6.84% |
| 2019 | $76.51 Million | +75.89% |
| 2018 | $43.50 Million | +26.81% |
| 2017 | $34.30 Million | -68.82% |
| 2016 | $110.02 Million | -17.32% |
| 2015 | $133.06 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Dignitana AB (publ.) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.69 Million USD |
| MoneyControl | $13.69 Million USD |
| MarketWatch | $13.69 Million USD |
| marketcap.company | $13.69 Million USD |
| Reuters | $13.69 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.